Hospital Research studies

Kaiser Permanente’s diverse Southern California membership, our electronic medical record, and our integrated care model provide the ideal environment for our researchers to study and develop ways of improving hospital care. Some of our studies have evaluated strategies to help reduce the chance that patients will be readmitted to the hospital and assessed the safety of seasonal flu vaccination for surgical patients.

Kaiser Permanente Southern California and Novavax Collaboration on RSV Epidemiology

The purpose of this study is to provide critical information about the predictors of severe RSV disease, describe epidemiology and burden of hospitalized RSV disease in older adults, and assess healthcare utilization associated with hospitalized RSV disease in older adults in a community setting. A population of hospitalized older adults testing positive for influenza will also be identified for comparison purposes.

Principal Investigator:

Hung Fu Tseng, PhD, MPH

Funding Source:

Novavax, Inc.

Funding Years:

2016 - 2018

Post-licensure observational safety surveillance study of quadrivalent meningococcal ACWY conjugate vaccine

This study is an observational post-marketing safety study required by the United States Food and Drug Administration (FDA). The primary objective of this study is to describe medical events that require emergency room visit or hospitalization in 6 months following MenACWY-CRM vaccination in children 2-23 months of age in a health maintenance organization (HMO) in the United States.

Principal Investigator:

Hung Fu Tseng, PhD, MPH

Funding Source:

Novartis Vaccines and Diagnostics, Inc.

Funding Years:

2014 - 2018